drug · protein
insulin efsitora alfa
pre_registrationupdated 5mo agoby Eli Lilly and Co🔗 ChEMBL
community read0 votes
Protein drug with a maximum clinical stage of Phase 3 (across all indications), with 2 investigational indications.
indications
indications
Type 2 Diabetes
all catalysts(0)
nothing on the calendar yet
Trials studying insulin efsitora alfa
- phase3A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)
- phase3A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
- phase3A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin
- phase3A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time
- phase3A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections
News(1)
- Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalryThe weekly insulin Onswik will now be available to U.S. patients after initial approvals in Europe, Mexico and Japan.biospace · 9d ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that